KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Receivables (2016 - 2025)

Zoetis (ZTS) has disclosed Receivables for 14 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • Quarterly Receivables rose 18.92% to $1.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Dec 2025, up 18.92% year-over-year, with the annual reading at $1.7 billion for FY2025, 18.92% up from the prior year.
  • Receivables for Q4 2025 was $1.7 billion at Zoetis, up from $1.5 billion in the prior quarter.
  • The five-year high for Receivables was $1.7 billion in Q4 2025, with the low at $1.1 billion in Q1 2021.
  • Average Receivables over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2022.
  • The sharpest move saw Receivables decreased 2.95% in 2023, then grew 18.92% in 2025.
  • Over 5 years, Receivables stood at $1.2 billion in 2021, then increased by 8.98% to $1.3 billion in 2022, then rose by 5.91% to $1.4 billion in 2023, then increased by 2.42% to $1.4 billion in 2024, then increased by 18.92% to $1.7 billion in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $1.7 billion, $1.5 billion, and $1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.